Just in the previous years, scientists have recognized the huge role that the microorganisms living inside and on us play in our health. The human microbiome, and especially the gut microbiome, has actually been linked to several persistent illness, including diabetes. An out of balance microbiome composition has been found in patients with diabetes, who tend to have a less diverse gut microbiome as compared to healthy individuals. Retail.
Some companies are establishing diabetes treatments targeting the microbiome. The French Valviotis is currently conducting preclinical screening of a drug aimed at increasing the microbiome diversity as a treatment for type 2 diabetes. Although appealing, the microbiome field is very young and its intricacy makes it hard to establish causation after finding connection.
That world may not be so far away, as numerous companies are establishing non-invasive approaches to substitute finger pricking. Retail. Integrity Applications has established a gadget called GlucoTrack that can determine glucose using electromagnetic waves and is currently readily available in Europe. Comparable innovations are appearing, with GlucoSense in London using laser light to determine sugar levels and MediWise making use of radio waves.
The GlucoWise sensing unit prototypePatches are also becoming a popular form of measuring blood sugar without needles, such as FreeStyle Libre, an inch-wide patch that can be used for up to 2 weeks. At the University of Bath, researchers are establishing a graphene spot that might offer greater accuracy by determining sugar levels individually in numerous hair follicles – Retail.
Meanwhile, Senseonic and Roche are working on a device that is implanted under the skin. Retail. Still, non-invasive alternatives to determine blood sugar level frequently deal with concerns regarding accuracy. The popular glucose-measuring contact lens that Google revealed in 2014 was dismissed as “technically infeasible” and further advancements will be needed to reach the degree of accuracy of finger-pricking approaches.
Researchers are already hypothesizing about microchips that can detect diabetes type 1 before the symptoms appear or nanorobots taking a trip in the blood stream while they measure glucose and provide insulin – Retail.”There’s little fiction left in this. I strongly believe that microrobotics will come and will become part of our drug shipment within the next 10 years,” stated Tomas Landh, Director of Technique and Development Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Yearly MeetingWhatever the future brings, it will unquestionably make a substantial distinction in the lives of countless individuals worldwide.